Company Profiles

driven by the PitchBook Platform

Asuragen

Description

Developer of diagnostic products. The company designs and develops diagnostic devices that helps medical professionals to understand critical clinical situations.

2005

Founded

PRIVATE

Status

51-200

Employees

Series C

Latest Deal Type

$7.5M

Latest Deal Amount

$79.9M

Total Amount Raised

Description

Developer of diagnostic products. The company designs and develops diagnostic devices that helps medical professionals to understand critical clinical situations.

Website:

www.asuragen.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

2150 Woodward Street Suite 100 Austin, TX 78744United States +1 (512) 681-5200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Asuragen's full profile, request a free trial.

Asuragen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Asuragen Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Asuragen Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Merck Global Health InnovationCorporate Venture CapitalMinority000 0000000 0000
PTV Healthcare CapitalVenture CapitalMinority000 0000000 0000
Southwest Middle Market M&AMerchant Banking FirmMinority000 0000000 0000
Telegraph Hill PartnersVenture CapitalMinority000 0000000 0000
Merck Global Health Innovation Corporate Venture Capital
PTV Healthcare Capital Venture Capital
Southwest Middle Market M&A Merchant Banking Firm
Telegraph Hill Partners Venture Capital

Asuragen Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Matthew McManus MDChief Executive Officer, President & Director
Lynne HohlfeldChief Financial Officer & Senior Vice President, Corporate Development
Matthew Winkler Ph.DFounder, Chairman & Chief Scientific Officer
Colin HillSenior Vice President Commercial Operations
Frederick Fletcher Ph.DSenior Vice President, Operations
Matthew McManus MD Chief Executive Officer, President & Director
Lynne Hohlfeld Chief Financial Officer & Senior Vice President, Corporate Development
Matthew Winkler Ph.D Founder, Chairman & Chief Scientific Officer
Colin Hill Senior Vice President Commercial Operations
Frederick Fletcher Ph.D Senior Vice President, Operations

Asuragen Board Members (6)

NameRepresentingRoleSinceContact
Info
David Rubin Ph.DMerck & Co.Board Member000 0000
Evan Melrose MDSelfBoard Member000 0000
J. Matthew MackowskiTelegraph Hill PartnersBoard Member000 0000
Lyle Arnold Ph.DSelfBoard Member000 0000
Matthew CrawfordPTV Healthcare CapitalBoard Member000 0000
David Rubin Ph.D Board Member Merck & Co.
Evan Melrose MD Board Member Self
J. Matthew Mackowski Board Member Telegraph Hill Partners
Lyle Arnold Ph.D Board Member Self
Matthew Crawford Board Member PTV Healthcare Capital
Request full access to PitchBook